Michael Taylor

Michael started his career working in bioprocessing for organizations like Genzyme and Baxter, then worked in business development for platforms supplying critical components of the biomanufacturing processes. For the past 15 years, he has expanded his expertise in the business development space for CRO/CDMO organizations, focusing on helping clients place their biologics programs into commercial manufacturing. He has an extensive understanding of client needs within mammalian cell culture, large scale commercial, and microbial production as well as other areas, supporting programs ranging in size from $1M to 300M. At Scorpius, Michael is focusing the western half of the United States for the CDMO capabilities and the analytical support services for their U.S.-based biomanufacturing.